Carbapenems are the treatment of choice for infections caused by ESBL-producing bacteria, and several studies have already reported the predominance of ESBL-Kp isolated from hospitals and emphasized its commonness in IAI and UTI [24]. Here, NPPA is linked to bacterial urinary tract infection.